← FDA Drug Approvals (Drugs@FDA)

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2017-04-28

Drug application

FDA Application #

ANDA207712

Application type

Abbreviated New Drug Application (Generic)

Brand name

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

Generic name

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

Active ingredients

AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

APOTEX

Manufacturer

Apotex Corp.

First approval

2017-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown